#TeamVaccines
Launched in early 2021 by IFPMA in response to the COVID-19 global pandemic, #TeamVaccines is the...
Because one-third of the world’s population does not have access to quality healthcare solutions, Sanofi is committed to exploring ways to ensure patients get the treatments they need and improving their quality of life.
As a health journey partner, Sanofi focus on one objective: improving access to healthcare and high-quality medications and vaccines for underserved populations in our fields of expertise by:
Improving access to healthcare requires tackling various barriers. It means innovating to address unmet medical needs and develop new solutions to bring healthcare to patients, ensuring that the conditions are in place in terms of production, supply chain and market access, to make the products and treatments available to patients. It also means building capacity and awareness for stronger healthcare systems. Finally, improving the affordability of products, treatments and related services is also crucial.
In that regard, Sanofi has prioritized three types of activities:
SHOWING 5 of 27 COLLABORATIONS
See AllLaunched in early 2021 by IFPMA in response to the COVID-19 global pandemic, #TeamVaccines is the...
The diabetes and hypertension clinics in sub-saharan Africa aim to improve the management of diabetes and...
The P5 aims to produce a HIV vaccine that could have a significant public health benefit in southern Africa...
GlaxoSmithKline, SanofiAn innovative awareness approach : since 2001, in partnership with National Malaria Control Programmes in...
On 30 January 2012, pharmaceutical companies, donors, endemic countries and non-government organisations came...
AbbVie, Bayer AG, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Novartis, Pfizer Inc, SanofiSHOWING 5 of 27 COLLABORATIONS
See All